Industry Insights Logo

Optimizing Your 340B Program: Ensuring Accurate Capture and Identifying Data Gaps

SPONSORED CONTENT

The 340B Drug Pricing Program offers significant savings to eligible healthcare organizations, enabling them to stretch scarce resources further and provide better services to their communities. However, ensuring your program captures the maximum potential savings and operates optimally requires close monitoring of

Read More »

Trump Selects Key Player in Anti-340B ‘Dark Money’ Campaign to Join New Department of Government Efficiency

President-elect Donald Trump (R) has selected Katie Miller as one of his first picks for his Department of Government Efficiency.
The chairperson of a political action committee with multiple links to a conservative dark money group that ran multiple controversial [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Staff, Members for Key Congressional Committees That Oversee 340B Policy Announced; REH Bill Reintroduced

Lawmakers introduced one 340B-related bill as the new narrowly GOP-controlled Congress began its work on Jan. 3.
The 119th Congress officially convened last week, kicking-off a two-year term that could bring about long-awaited updates to the 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Drugmaker Lawsuit Targets 340B Eligibility of In-Kind STD Clinics; STD Grantee Denies Allegations

Three drugmakers sued HRSA in federal court over 340B eligibility for certain STD clinics, including Sagebrush Health.
Three large drugmakers are suing the federal government for allegedly allowing certain STD clinics to unlawfully participate in the 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

AHA Urges CMS to Block Drugmaker 340B Rebate Models, Improve Medicare Transaction Facilitator

The AHA raised concerns that October 2024 federal guidance on Medicare drug price negotiations may allow drugmakers to “wrongly justify fundamental changes to the 340B program.”
A major hospital advocacy group recently warned that October 2024 agency guidance on Medicare drug price negotiations may allow drugmakers [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Indiana State Senator Renews Push for 340B Provider Reporting Bill in New Legislative Session

Indiana state capitol building
An influential Indiana state legislator plans to soon reintroduce legislation that would add extensive 340B reporting requirements for all 340B covered entity types after a similar bill stalled last year.
An influential Indiana state legislator plans to soon reintroduce legislation that would add extensive 340B reporting requirements for all 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live